These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2257225)

  • 1. Cisplatin and CCNU synergism in spheroid cell subpopulations.
    Durand RE
    Br J Cancer; 1990 Dec; 62(6):947-53. PubMed ID: 2257225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of CCNU toxicity by AF-2 in V79 spheroids: implications for mechanisms of chemosensitization.
    Durand RE; Olive PL
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1375-8. PubMed ID: 3759558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism of cisplatin and mitomycin C in sensitive and resistant cell subpopulations of a tumor model.
    Durand RE
    Int J Cancer; 1989 Nov; 44(5):911-7. PubMed ID: 2511158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of cell subpopulations in spheroids to radiation-drug combinations.
    Durand RE; Vanderbyl SL
    NCI Monogr; 1988; (6):95-100. PubMed ID: 3352795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between tumour geometry and the response of tumour cells to cytotoxic drugs--an in vitro study using EMT6 multicellular spheroids.
    Kwok TT; Twentyman PR
    Int J Cancer; 1985 May; 35(5):675-82. PubMed ID: 3997287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
    Durand RE; Chaplin DJ
    Br J Cancer; 1987 Aug; 56(2):103-9. PubMed ID: 3663461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of etoposide and cisplatin in an in vitro tumor model.
    Durand RE; Goldie JH
    Cancer Treat Rep; 1987; 71(7-8):673-9. PubMed ID: 3607781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemosensitivity testing in V79 spheroids: drug delivery and cellular microenvironment.
    Durand RE
    J Natl Cancer Inst; 1986 Jul; 77(1):247-52. PubMed ID: 2425117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
    Hirst DG; Brown JM; Hazlehurst JL
    Br J Cancer; 1982 Jul; 46(1):109-16. PubMed ID: 7201845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea.
    Fischel JL; Formento P; Etienne MC; Gioanni J; Frenay M; Deloffre P; Bizzari JP; Milano G
    Cancer Chemother Pharmacol; 1990; 25(5):337-41. PubMed ID: 2306793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response to cytotoxic drugs of EMT6 cells treated either as intact or disaggregated spheroids.
    Kwok TT; Twentyman PR
    Br J Cancer; 1985 Feb; 51(2):211-8. PubMed ID: 3966978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schedule-dependent potentiation of lomustine cytotoxicity by amphotericin B in mice.
    Valeriote F; Dieckman J; Chabot G
    J Natl Cancer Inst; 1986 Mar; 76(3):521-5. PubMed ID: 3456466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a tritiated thymidine suicide technique in the study of the cytotoxic drug response of cells located at different depths within multicellular spheroids.
    Kwok TT; Twentyman PR
    Br J Cancer; 1987 Apr; 55(4):367-74. PubMed ID: 3034319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemosensitization of CCNU in KHT murine tumor cells in vivo and in vitro by the agent RB 6145 and its isomer PD 144872.
    Siemann DW
    Radiother Oncol; 1995 Jan; 34(1):47-53. PubMed ID: 7792398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea's toxicity in vitro by two new bioreductive agents.
    Papadopoulou MV; Mainwaring A; Bloomer WD
    Jpn J Cancer Res; 1992 Aug; 83(8):907-13. PubMed ID: 1399828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of changes in oxygen tension, pH, and glucose concentration on the response to CCNU of EMT6 mouse tumor monolayer cells and multicellular spheroids.
    Kwok TT; Twentyman PR
    Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1221-9. PubMed ID: 3384723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermochemotherapy with cis-platinum, CCNU, BCNU, chlorambucil and melphalan on murine marrow and two tumours: therapeutic gain for melphalan only.
    Honess DJ; Bleehen NM
    Br J Radiol; 1985 Jan; 58(685):63-72. PubMed ID: 4063642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
    Mulcahy RT
    Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative distinction of cisplatin-sensitive and -resistant mouse fibrosarcoma cells grown in multicell tumor spheroids.
    Frenzel KR; Saller RM; Kummermehr J; Schultz-Hector S
    Cancer Res; 1995 Jan; 55(2):386-91. PubMed ID: 7812971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.